Serum Institute Of India : All

You deserve independent, critical media. Subscribe and Support

Richa Chintan
Big Pharma– Maximum Earnings, Minimum Responsibilities
23 Aug 2021
The pandemic has again exposed the true nature of capitalism with profit being the primary driver irrespective of the rising inequalities.
Neelambaran A
COVID-19: Vaccine Shortage Looms Large But IVC Facility in Tamil Nadu Awaits Centre’s Attention
07 Jun 2021
Several Left and DMK MPs have written to the Union government seeking aid for the manufacturing facility in Chengalpattu, but to no avail.
Newsclick Report
AIPSN Statement Urges Govt to Expand Public and Private Sector COVID-19 Vaccine Production
01 Jun 2021
Criticising the government’s current vaccine policy, the statement notes that India has neglected its public sector units, because of which 90% of India’s vaccines for the Universal Immunisation…
Newsclick Report
'Urgently Expand Public and Private Sector Production': Scientists Urge Govt. on COVID-19 Vaccination
28 May 2021
'Both SII and Bharat Biotech could be appropriately persuaded to handhold these other units as one way of paying back their own long-standing obligations to the public sector and the Indian state,'…
Prof M Sridhar Acharyulu
Centre’s Vaccine Policy is Anti-Democratic and Unconstitutional
17 May 2021
The new vaccine policy of the Centre is in absolute violation of Article 21 (Right to Life) that includes right to health, as access has been unduly made unaffordable. It also violates Article 14…
Sanjay Kumar
Black Economy of Modi Government’s Vaccine Policy
14 May 2021
The Modi government’s handling of the Covid-19 epidemic is a continuing disaster for India.
Newsclick Report
India’s Covid Vaccine Price in Private Sector Ranges from Rs 700- Rs 1500, Among World’s Costliest
10 May 2021
With high prices and limited supply, the major chunk of the vaccination in the private sector is being dominated by four big corporate hospital groups--Apollo, Max, Fortis and Manipal.
PTI
COVID-19: PIL Seeks Sale of Vaccines by SII, Bharat Biotech at Rs 150
28 Apr 2021
'These pharma giants are milking the fear psychosis of the increased death rates due to COVID-19,' the PIL filed on April 24 said.
Shubham Sharma
Nationalise Vaccine Production in National Interest!
27 Apr 2021
The Indian government lacks proper vaccine manufacturing facilities—a tragedy that has been in the making for well over a decade now.
Sandipan Talukdar
Covid-19 Crisis: Lack of Key Data and Gaps in India’s Preparation for Second Wave
26 Apr 2021
As the second wave ravages India, it is important to see to whether the country failed in managing the numbers in terms of people tested, traced, vaccinated, and sequencing of viral strains.